Physix Frontier · News Briefing Card (IT Home · Oct 16, 2026)

Google Antigravity uses AI to find new antimicrobial peptide candidate

KEY FACTS

  • Google launched the Antigravity intelligent development platform to accelerate antimicrobial peptide discovery.
  • The platform uses the ProtNLM model to predict protein function directly from amino acid sequences.
  • Researchers have already used the platform to discover a new antimicrobial peptide candidate.
  • The candidate is predicted to be active against respiratory infection pathogens and is undergoing wet-lab validation.
  • The platform compresses cross-database screening from days into a single collaborative session.

PHYSIX OBSERVATION

AI is shifting from an auxiliary tool to the research workflow itself. Antigravity folds scattered database searches, structural analysis, and literature synthesis into a single session, meaning the barrier to drug discovery is dropping and the bottleneck is moving from information access to experimental validation. The antimicrobial peptide direction is worth watching, but wet-lab validation is the real touchstone.

Source: IT Home report